679. Retrospective Analysis of Vancomycin and Fidaxomicin for the Treatment of Recurrent Clostridioides difficile Infection

BACKGROUND: It is estimated that one out of every six patients with a Clostridioides difficile infection (CDI) will develop a recurrence. Guidelines recommend treatment with fidaxomicin rather than vancomycin standard course or tapered and pulsed regimens for the treatment of recurrent CDI (rCDI). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabian, Amy, Frantz, Tyler, Patel, Rachana, Kier, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677751/
http://dx.doi.org/10.1093/ofid/ofad500.741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677751/
http://dx.doi.org/10.1093/ofid/ofad500.741

Ejemplares similares